Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main Nektar Therapeutics Transaction History
Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main
- $92.1 Billion
- Q2 2024
A detailed history of Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main transactions in Nektar Therapeutics stock. As of the latest transaction made, Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main holds 187,385 shares of NKTR stock, worth $219,240. This represents 0.0% of its overall portfolio holdings.
Number of Shares
187,385
Previous 288,634
35.08%
Holding current value
$219,240
Previous $268,000
13.43%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding NKTR
# of Institutions
140Shares Held
135MCall Options Held
32.8KPut Options Held
55.5K-
Deep Track Capital, LP Greenwich, CT17.9MShares$20.9 Million0.73% of portfolio
-
Black Rock Inc. New York, NY15.2MShares$17.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA13MShares$15.2 Million0.0% of portfolio
-
Samlyn Capital, LLC New York, NY9.46MShares$11.1 Million0.21% of portfolio
-
Eventide Asset Management, LLC Boston, MA7.53MShares$8.81 Million0.16% of portfolio
About NEKTAR THERAPEUTICS
- Ticker NKTR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 187,404,992
- Market Cap $219M
- Description
- Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...